Molecular genetics of late-onset Alzheimer's disease

Annals of Human Genetics

Volumn 68, Issue 4, 2004, Pages 381-404

  Kamboh, M Ilyas ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 6; CHROMOSOME 9; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HERITABILITY; HUMAN; MARKER GENE; MOLECULAR GENETICS; ONSET AGE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; HUMANS; LINKAGE (GENETICS); MOLECULAR BIOLOGY;

EID: 4444302117     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8817.2004.00110.x     Document Type: Review

References (130)

1. Abraham, R., Myers, A., Wavrant-DeVrieze, F. et al. (2001) Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 109, 646-652.
2. Alzheimer, A. (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift fur Psychiatrie and Psychisch-Gerichtliche Medizin 64, 146-148.
3. Arinami, T., Takekoshi, K., Yanagi, H. et al. (1996) The 5-reapeat allele in the very-low-density lipoprotein receptor gene polymorphism is not increased in sporadic Alzheimer's disease in Japanese. Neurology 47, 1349-1350.
4. Bacanu, S. A., Devlin, B., Chowdari, K. V. et al. (2002) Linkage analysis of Alzheimer's disease with psychosis. Neurology 59, 118-120.
5. Ballerini, C., Nacmias, B., Rombola, G. et al. (1999) HLA A2 allele is associated with age of onset of Alzheimer's disease. Ann Neurol 45, 397-400.
6. Berg, K. E., Tian, H., Graf, G. A. et al. (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290, 1771-1779.
7. Bertram, L., Blacker, D., Crystal, A. et al. (2000a) Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp Gerontol 35, 1353-1361.
8. Bertram, L., Blacker, D., Mullin, K. et al. (2000b) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290, 2302-2303.
9. Bertram, L., Saunders, A. J., Mullin, K. et al. (2003) No association between marker D10S1423 and Alzheimer's disease. Mol Psychiatry 8, 571-573.
10. Bertram, L., Parkinson, M., Mullin, K., Menon, R., Blacker, D. & Tanzi, R. E. (2004) No association between a previously reported OLR1 3/UTR polymorphism and Alzheimer's disease in a large family sample. J Med Genet 41, 286-288.
11. Beyer, K., Lao, J. I., Gomez, M. et al. (2001) Alzheimer's disease and the cystatin C gene polymorphism: an association study. Neurosci Lett 315, 17-20.
12. Bing, Z., Reddy, S. A., Ren, Y. et al. (1999) Purification and characterization of the serum amyloid A3 enhancer factor. J Biol Chem 274, 24649-24656.
13. Blacker, D., Bertram, L., Saunders, A. J. et al. (2003) Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12, 23-32.
14. Blomqvist, M. E.-L., Andreasen, N., Bogdanovic, N., Blennow, K., Brookes, A. J. & Prince, J. A. (2004) Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease. Neurosci Lett 358, 220-222.
15. Boussaha, M., Hannequin, D., Verpillat, P. et al. (2002) Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett 329, 121-123.
16. Bowirrat, A., Friedland, R. P, Chapman, J. & Korczyn, A. D., (2002) The very high prevalence of Alzheimer's disease in an Arab population is not explained by the APOE€4 allele frequency. Neurology 55, 731.
17. Bullido, M. J., Artiga, M. J., Recuero, M. et al. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18, 69-71.
18. Brown, P. O. & Botstein. D. (1999) Exploring the new world of the genome with DNA microarrays. Nat Genet (suppl) 21, 33-37.
19. Callow, M.J. & Rubin, E. M. (2002) Expression and comparative sequence derived insights into lipid metabolism. Curr Opin Lipidol 13, 173-179.
20. Chen, L., Baum, L., Ng, H. K. et al. (1998) No association between very-low-density lipoprotein receptor (VLDL-R) and late-onset Alzheimer's disease in Hong Kong Chinese. Neurosci Lett 241, 33-36.
21. Chung, H., Roberts, C. T., Greenberg, S. et al. (1996) Lack of association of trinucleotide repeat polymorphism in the very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann Neurol 39, 800-803.
22. Collins, J. S., Perry, R. T., Watson, B. Jr. et al. (2000) Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 96, 823-830.
23. Combarros, O., Escribano, J., Sanchez-Velasco, P. et al. (1998) Association of the HLA-A2 allele with an earlier age of onset of Alzheimer's disease. Acta Neurol Scand 98, 140-141.
24. Crawford, F. C., Freeman, M. J., Schinka, J. A. et al. (2000) A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology 55, 763-768.
25. Curran, M. D., Middleton, D., Edwardson, J. A. et al. (1997) HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease. NeuroReport 8, 1467-1469.
26. Daw. E. W., Payami, H., Nemens, E. J. et al. (2002) The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66: 196-204.
27. De Strooper, B., Saftig, P., Craessaerts, K. et al. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390.
28. Edland, S. D., Wavrant-De Vriese, F., Compton, D. et al. (2003) Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE). Neurosci Lett 345, 21-24.
29. 42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290, 2303-2304.
30. Ertekin-Taner, N., Ronald, J., Asahara, H. et al. (2003) Fine mapping of the α-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Hum Mol Genet 12, 3133-3143.
31. Ertekin-Taner, N., Allen, M., Fadale, D., Scanlin, L., Younkin, L., Petersen, R. C., Graff-Radford, N. & Younkin, S. G. (2004) Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Aβ42 levels and risk for Alzheimer disease. Hum Mutat 23, 334-342.
32. Fallin, D., Gauntlett, A. C., Scibelli, P. et al. (1997) No association between the very-low-density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinical samples. Genet Epidemiol 14, 299-305.
33. Farrer, L. A., Bowirrat, A., Friedland, R. P. et al. (2003) Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet 12, 415-422.
34. Farrer, L. A., Cupples, L. A., Haines, J. L. et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349-1356.
35. Finckh, U., Van Hadeln, K., Muller-Thomsen, T. et al. (2003) Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics 4, 213-217.
36. Finckh, U., von der Kammer, H., Velden, J. et al. (2000) Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol 57, 1579-1583.
37. Friedlander, R. M. (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348, 1365-1375.
38. Goate, A. M., Chartier-Harlin, M.-C., Mullan, M. C. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
39. Goldstein, J. L. & Brown, M. S. (2001) The cholesterol quartet. Science 292, 1310-1312.
40. Götz, J., Chen, E, van Dorpe, J. et al. (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by AβP42 fibrils. Science 293, 1491-1495.
41. Grant, E. P, Pickard, M. D., Briskin, M. J. et al. (2002) Gene expression profiles. Creating new perspectives in arthritis research. Arthrit Rheum 46, 874-884.
42. Haines J. L., Bailey R., Grubber J. M. et al. (2001) A genomic search for Alzheimer's disease genes. In: Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics (eds. K. Iqbal, S. S. Sisodia and B. Winblad), pp. 33-43. Chichster: John Wiley & Sons.
43. Haines, J. L., Pritchard, M. L., Saunders, A. M. et al. (1996) No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. Genomics 33, 53-56.
44. Harold, D., Peirce, T., Moskvina, V et al. (2003) Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet 113, 258-267.
45. Hegele, R. A. (2001) Monogenic dyslipidemias: Window on determinants of plasma lipoprotein metabolism. Am J Hum Genet 69, 1161-1177.
46. Hiltunen, M., Mannermaa, A., Thompson, D. et al. (2001) Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. Neurology 57, 1663-1668.
47. Holmans, P, Myers, A., Hardy, J. et al. (2003) Evidence of interaction between susceptibility loci on chromosomes 1, 10 and 12 in late-onset Alzheimer's disease (LOAD). Am J Hum Genet 73(suppl):184 (abstract).
48. Holtzman, D. M., Balse, K. R., Tenkova, T. et al. (2000) Apolipoprotein E isoform-dependent and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 97, 2892-2897.
49. Kamboh, M. I., Aston, C. E., Perez-Tur, J. etal. (1999) A novel mutation in the apolipoprotein E gene (APOE* 4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Neurosci Lett 263, 129-132.
50. Kamboh, M. I., Sanghera, D. K., Ferrell, R. E. et al. (1995) APOE* 4-associated Alzheimer's disease risk is modified by al-antichymotrypsin polymorphism. Nat Genet 10, 486-488.
51. Kataoka, H., Kume, N., Miyamoto, S. et al. (2001) Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21, 955-960.
52. Kehoe, P, Wavrant-DeVrièze, F., Crook, R. et al. (1999) A full genome scan for late-onset Alzheimer's disease. Hum Mol Genet 8, 237-245.
53. Kostner, M. N., Dermaut, B., Cruts, M. et al. (2000) The α2-macroglobulin gene in AD. A population-based study and meta analysis. Neurology 55, 678-684.
54. Kounnas, M., Moir, R., Rebeck, W et al. (1995) LDL receptor related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331-340.
55. Lambert, J.-C., Berr, C., Pasquier, F. et al. (1998) Pronounced impact of Th1/E47cs mutation compared with - 491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 7, 1511-1516.
56. Lambert, J.-C., Goumidi, L., Wavrant-DeVrièze, F. et al. (2000) The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 9, 2275-2280.
57. Lambert, J. C., Luedecking-Zimmer, E., Merrot, S. et al. (2003) Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet 40, 424-430.
58. Lee, J. H., Mayeux, R., Mayo, D. et al. (2004) Fine mapping on 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics. Mol Psychiatry (in press).
59. Lawn, R. M., Wade, D. P, Garvin, M. R. et al. (1999) The tangier disease gene product ABCA1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104, R25-R31.
60. Leon, J., Cheng, C. K. & Neumann, P J. (1998) Alzheimer's disease care: costs and potential savings. Hlth Affairs 17, 206-216.
61. Levy-Lahad, E., Wasco, W , Poorkaj, P. et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
62. Lewis, J., Dickson, D. W, Lin, W-L. et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491.
63. Li, Y-J., Scott, W. K., Hedges, D. J. et al. (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70, 985-993.
64. Li, Y.-J., Oliveira, S. A., Xu, P, et al. (2003) Gluthione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12, 3259-3267.
65. Liu, L., Forsell, C., Lilius, L. et al. (1996) Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families. Am J Med Genet 67, 306-311.
66. Luedecking-Zimmer, E., DeKosky, S. T., Chen, Q. et al. (2002) Investigation of oxidized LDL-receptor 1 (OLR 1) as the candidate gene for Alzheimer's disease on chromosome 12. Hum Genet 111, 443-451.
67. Luedecking-Zimmer, E., DeKosky, S. T., Nebes, R. et al. (2003) Association of the 3′ UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease. Am J Med Genet (Neuropsychiatr Genet) 117B, 114-117.
68. Majores, M., Bagli, M., Papassotiropoulos, A. et al. (2000) Allelic association between the D10S1423 marker and Alzheimer's disease in a German population. Neurosci Lett 289, 224-226.
69. Maruyama, H., Izumi, Y, Oda, M. et al. (2001) Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's disease. Neurology 57, 337-339.
70. Mayeux, R., Lee, J. H., Romas, S. N. et al. (2002) Chromosome-12 mapping of late-onset Alzheimer's disease among Carribean Hispanics. Am J Hum Genet 70, 237-243.
71. McCusker, S. M., Durran, M. D., Dynan, K. B. et al. (2001) Association between polymorphisms in regulatory region of gene encoding tumor necrosis factor a and risk of Alzheimer's disease and vascular dementia: A case-control study. Lancet 357, 436-439.
72. Middleton, D., Mawhinney, H., Curran, M. D. et al. (1999) Frequency of HLA-A and HLA-B alleles in early and late-onset Alzheimer's disease. Neurosci Lett 262, 140-142.
73. Mubumbila, V., Sutter, A., Ptok, U. et al. (2002) Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neurosci Lett 333, 9-12.
74. Myers, A., Holmans, P., Marshall, H. et al. (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290, 2304-2305.
75. Myers, A., Wavrant De-Vrieze, F, Holmans, P. et al. (2002) Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet (Neuropsychiatr Genet) 114, 235-244.
76. Myers, A. J., Marshall, H., Holmans P. et al. (2004) Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD. Am J Med Genet (Neuropsychiatr Genet) 124B: 29-37.
77. Myers, M. R., Tschanz, J. T., Norton M. C. et al. (1998) APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer's disease. Nat Genet 19, 321-322.
78. Nielson, T. O., West, R. B., Linn, S. C. et al. (2002) Molecular characterization of soft tissue tumors: a gene expression study. Lancet, 359, 1301-1307.
79. Nishimura, A. L., Oliveira, J. R., Otto, P. A. et al. (2001) No evidence of association between the D10S1423 locus and Alzheimer disease in Brazilian patients. J Neural Transm 108, 305-310.
80. Nussbaum, R. L. & Ellis, C. E. (2003) Alzheimer's disease and Parkinson's disease. N Engl J Med 348, 1356-1364.
81. Oka, K., Sawamura, T., Kikuta, K. et al. (1998) Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci USA 95, 9535-9540.
82. Okuizumi, K., Onodera, O., Namba, Y. et al. (1995) Genetic association of the very low density lipoprotein (VLDLR) receptor gene with sporadic Alzheimer's disease. Nat Genet 11, 207-209.
83. Okuizumi, K., Onodera, O., Seki, K. et al. (1996) Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann Neurol 40, 251-254.
84. Olson, J. M., Goddard, K. A. & Dudek, D. M. (2001) The amyloid precursor protein locus and very-late-onset Alzheimer disease. Am J Hum Genet 69, 895-899.
85. Olson, J. M., Goddard, K. A. & Dudek, D. M. (2002) A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet 71, 154-161.
86. Payami, H., Kaye, J., Becker, W. et al. (1991) HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men. Neurology 41, 1544-1548.
87. Payami, H., Schellenberg, G. D., Zareparsi, S. et al. (1997) Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease. Neurology 49, 512-518.
88. Pederson, N. L., Gatz, M., Berg, S. & Johansson, B. (2004) How heritable is Alzheimer's disease late in life? Finding from Swedish twins. Ann Neurol 55, 180-185.
89. Pericak-Vance, M. A., Bass, M. P, Yamaoka, L. H. et al. (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278, 1237-1241.
90. Pericak-Vance, M. A., Johnson, C. C., Rimmler, J. B. et al. (1996) Alzheimer's diseases and apolipoprotein E-4 allele in an Amish population. Ann Neurol 39, 700-704.
91. Pericak-Vance, M. A., Grubber, J., Bailey, L. R. et al. (2000) Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 35, 1343-1352.
92. Poduslo, S. E. & Yin, X. (2001) Chromosome 12 and late-onset Alzheimer's disease. Neurosci Lett 310, 188-190.
93. Prince J. A., Feuk, L., Gu, H. F. et al. (2003) Genetic variation in a haplotype block spanning IDE influences Alzheimer's disease. Hum Mut 22, 363-371.
94. Pritchard, M. L., Saunders, A. M., Gaskell, P. C. et al. (1996) No association between very-low-density lipoprotein receptor (VLDL-R) and Alzheimer's disease in American Caucasians. Neurosci Lett 209, 105-108.
95. Rebeck, G. W., Harr, S. D., Strickland, D. K. et al. (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 37, 211-217.
96. Renvoize, E. B. (1984) An HLA and family study of Alzheimer's disease. Psychol Med 14, 515-520.
97. Roberts, S. B., MacLean, C. J., Neale, M. C. et al. (1999) Replication of linkage studies of complex traits: an examination of variation in location estimates. Am J Hum Genet 65, 876-884.
98. Rocca, W A., Hofman, A., Brayne, C. et al. (1991) Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence finding. Ann Neurol 30, 381-390.
99. Rogaeva, E., Prekumar, S., Song, Y. et al. (1998) Evidence for an Alzheimer's disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 280, 614-618.
100. Rogaeva, E. I., Sherrington, R., Rogaeva, E. A. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
101. Roses, A. D. (1995) Alzheimer's disease as a model of molecular gerontology. J NIH Res 7, 51-57.
102. Sakai, A., Ujike, H., Nakata, K., Takehisa, Y, Imamura, T, Uchida, N., Kanzaki, A., Yamamoto, M., Fujisawa, Y, Okumura, K. & Kuroda, S. (2004) No association between the insulin degrading enzyme and Alzheimer's disease in a Japanese population. Am J Med Genet (Neuropsychiatr Genet) 125B, 87-91.
103. Saunders, A. J., Bertram, L., Mullin, K. et al. (2003) Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Hum Mol Genet 12, 2765-2776.
104. Schwarz, S., Eisele, T., Diehl, J. et al. (2003) Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease. Neurosci Lett 343, 167-170.
105. Scott, W. K., Grubber, J. M., Conneally, P. M. et al. (2000) Fine mapping of the chromosome 12 late-onset Alzheimer's disease locus. Potential genetic and phenotypic heterogeneity. Am J Hum Genet 66, 922-932.
106. Scott, W. K., Hauser, E. R., Schemechel, D. E. et al. (2003) Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. Am J Hum Genet 73, 1041-1051.
107. Seshadri, S., Drachman, D. A. & Lippa, C. F. (1995) Apolipoprotein E€4 allele and lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch Neurol 52, 1074-1079.
108. Sherrington, R., Rogaev, E. I., Liang, Y. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
109. Slooter, A. J., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M. M., Van Broeckhoven, C. et al. (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55, 964-968.
110. Song, Y.-Q., Rogaeva, E., Premkumar, S. et al. (1998) Absence of association between Alzheimer disease and the - 491 regulatory region polymorphism of APOE. Neurosci Lett 250, 189-192.
111. Sorlie, T., Perou, G. M., Tibshirani, R. et al. (2001) Gene expression pattern of breast carcinomas distinguish tumor subclass with clinical implication. Proc Natl Acad Sci USA 98, 10869-10874.
112. Stanton, K. C., Jiang, L., Schnetz-Boutaud, N. et al. (2003) Further evidence of linkage of Alzheimer's disease on chromosome 12. Am J Hum Genet 73(suppl): 471 (abstract).
113. Sweet, R. A., Nimgaonkar, V. L., Devlin, B. & Jeste, D. V. (2003) Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry 8: 383-392.
114. Takahashi, S., Oida, K., Ookubo, M. et al. (1996) Very-low density lipoprotein receptor binds apolipoprotein E 2/2 as well as apolipoprotein E 3/3. FEBS Lett 386, 197-200.
115. Tandon, A., Rogaeva, E., Mullan, M. et al. (2000) Molecular genetics of Alzheimer's disease: the role of β-amyloid and the presenilins. Curr Opin Neurol 13, 377-384.
116. Tarkowski, E., Liljeroth, A.-M., Nilson, A. et al. (2000) TNF gene polymorphism and its relation to intracerebral production of TNF-a and TNF-β in AD. Neurology 54, 2077-2081.
117. Taylor, A. E., Yip, A., Brayne, C. et al. (2001) Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet 38, 232-233.
118. Toji, H., Maruyama, H., Sasaki, K. et al. (1999) Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population. Neurosci Lett 259, 56-58.
119. van Leeuwen, F. W., de Kleijn, D. P., van den Hurk, H. H. et al. (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279, 242-247.
120. van Leeuwen, F. W., Fischer, D. F., Kamel, D. et al. (2000) Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiol Aging 21, 879-891.
121. Vekrellis, K., Ye, Z., Qiu, W. Q. et al. (2002) Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20, 1657-1665.
122. Wang, X., DeKosky, S. T., Luedecking-Zimmer, E. et al. (2002) Genetic variation in α1-antichymotrypsin and its association with Alzheimer's disease. Hum Genet 110, 356-365.
123. Wang, X., Luedecking, E. K., Minster, R. L. et al. (2001) Lack of association between the α2-macroglobulin polymorphisms and Alzheimer's disease. Hum Genet 108, 105-108.
124. Wavrant-De Vrieze, F., Crook, R., Holmans, P. et al. (1999) Genetic variability at the amyloid-β precursor protein locus may contribute to the risk of late-onset Alzheimer's disease. Neurosci Lett 269, 67-70.
125. West, M. J., Coleman, P. D., Flood, D. G. et al. (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344, 769-772.
126. Wu, W S., Holmans, P., Wavrant-DeVrièze, W. et al. (1998) Genetic studies on chromosome 12 in late-onset Alzheimer's disease. JAMA 280, 619-622.
127. Xu, P.-T., Gilbert, J. R., Walters, S. N. et al. (2002) Characterization and analyses of AD candidate genes P16 and MTAP on chromosome 9p2l. Am J Hum Genet, 71(suppl):A490 (abstract).
128. Yamanaka, S., Zhang, X. Y., Miura, K. et al. (1998) The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics 54, 191-199.
129. Zambrano, N., Minopoli, G., de Candia, P. et al. (1998) The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J Biol Chem 273, 20128-20133.
130. Zubenko, G. S., Hughes, H. B., Stiffler, J. S. et al. (1998) A genome survey for novel Alzheimer's disease risk loci results at 10 cM resolution. Genomics 50, 121-128.